生命科学资讯

Immunology CRO RoukenBio pens pact with AVS Bio for more predictable antibody development

Moderna faces setback in Arbutus' mRNA patent fight

Illumina To Webcast Upcoming Investor Conference - cnhinews.com

Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering

Boehringer axes inhaled gene therapy after viewing cystic fibrosis data

Unlocking health data

Sequence to Substance: Making the mRNA Therapeutic

Appointments and advancements for Feb. 17, 2026

Financings for Feb. 17, 2026

In the clinic for Feb. 17, 2026

Other news to note for Feb. 17, 2026

Regulatory actions for Feb. 17, 2026

Compass, with Phase 3 hits, ready to take psilocybin to the FDA

10x Genomics (TXG) Is Down 5.4% After Shelf Offer Filing And Cautious 2026 Outlook What's Changed - simplywall.st

FDA rejects Disc Medicine's rare disease drug despite granting it a commissioner voucher

Ocular claims a win with eye drug data even as shares sink

Extracellular matrix sensing regulates intratumoral heterogeneity of autophagic flux

A single-cell time-series atlas of endothelial cell embryonic development

Sanofi points to 'key opportunity' for Teva-partnered IBD in long-term data

Compass guides psychedelic therapy to 2nd pivotal depression win, triggering approval push